Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Currency
EUR
Contact rapide
Veuillez m'envoyer plus d'informations sur
Fmoc-L-Asn(1GN,2G-(Fuc))-OH
Nom chimique: N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N4-((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4R,5S,6R)-3-acetamido-5-(((2S,3S,4S,5R,6R)-6-((((2S,3S,4S,5S,6R)-3-(((2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6- (hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydrox // Synonymes: Fmoc-Asn(1GN,2G-(Fuc))-OH, Common glycan name: G1F [3], Oxford glycan name: FA2[3]G1, Alternative Glycan names: FA2G1, G1F, GlyCosmos ID: G58667NI
- n° Art.:GCN1130
- Formule:C81H120N6O49
- Storage temperature:-20°C
- Masse moléculaire:1961,84 g/mol
- Pureté:min.90,0%
from 2 320,00 €
description
Fmoc-protected Asn-linked FA2G1 glycan for use in solid phase peptide synthesis (SPPS).
references
Prompt Chemoenzymatic Synthesis of Diverse Complex-Type Oligosaccharides and Its Application to the Solid-Phase Synthesis of a Glycopeptide with Asn-Linked Sialyl-undeca- and Asialo-nonasaccharides; Y. Kjihara, Y. Suzuki, N. Yamamoto, K. Sasaki, T. Sakakibara, L. R. Juneja; Chem. Eur. J. 2004; 10: 971-985. https://doi.org/10.1002/chem.200305115
Chemical Synthesis of Homogeneous Human Glycosyl-interferon-â That Exhibits Potent Antitumor Activity in Vivo; I. Sakamoto, K. Tezuka, K. Fukae, K. Ishii, K. Taduru, M. Maeda, M. Ouchi, K. Yoshida, Y. Nambu, J. Igarashi, N. Hayashi, T. Tsuji, Y. Kajihara; J. Am. Chem. Soc. 2012; 134: 5428−5431. https://doi.org/10.1021/ja2109079
Besoin d'informations supplémentaires sur ce produit?
entrer en contact
Des produits qui pourraient également vous intéresser!
